Andere talen Bionomics Australian S.E.

Aandelen

BNO

AU000000BNO5

Vertraagde tijd Australian S.E. Andere beurzen 08:10:06 24-08-2023			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,01 ^AUD	-.--%		-.--%	-.--%

21/03	Bionomics rapporteert resultaten van de volledige dataset analyse van de ATTUNE Fase 2b studie met BNC210 bij patiënten met posttraumatische stressstoornis	CI
15/03	Bionomics Limited rapporteert resultaten voor het halfjaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder	21/03
Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder	21/03
Bionomics : Notes to the Consolidated Financial Statements - Form 6-K	15/03
Bionomics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	15/03
Bionomics to Present at the 2024 BIO CEO & Investor Conference	22/02
Small-Cap Nasdaq Stocks to Watch Now! VTAK, BNOX, INBS, DYAI, KAVL	29/01
Wall Street Set to Open Higher in Monday Trading Ahead of Economic Indicators Data	22/01
US Futures Poised to Open Week Higher, Leading Economic Indicators on Tap	22/01
Bionomics Provides a Review of 2023 and of 2024 Plans	22/01
Bionomics to Present at Biotech Showcase™ 2024	05/01
Bionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting	06/12
Bionomics : Results of Annual General Meeting - Form 6-K	30/11
Bionomics : • Operations Presentation	30/11
Bionomics : Announces Retirement of Board Member - Form 6-K	28/11
Bionomics Limited Announces Retirement of Dr. Errol De Souza as Board of Directors, Effective November 30, 2023	28/11
Bionomics : Announces Retirement of Board Member	28/11
ADRs End Higher, Yoshitsu Co. Ltd. Climbs 19.2%	10/11
Bionomics : Notice of Annual General Meeting Explanatory Statement and Proxy Form - Form 6-K	03/11
Bionomics to Advance Social Anxiety Disorder Treatment Into Phase 3 Studies After End-of-Phase 2 Meeting With US FDA	16-10-23
Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA and Solidifies Plans to Initiate the Registrational Program for BNC210 in Social Anxiety Disorder	16-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bionomics Australian S.E.

Aandelen

BNO

AU000000BNO5

Andere talen

Filters